A Sub-Pathway Based Method to Identify Candidate Agents for Ankylosing Spondylitis

Abstract excerpt

The need for new therapeutics for Ankylosing Spondylitis (AS) is highlighted by the general lack of efficacy for most agents currently available for this disease. Many recent studies have detailed molecular pathways in AS, and several molecule-targeting agents are undergoing evaluation. We aimed to explore the mechanism of AS and identify biologically active small molecules capable of targeting the sub-pathways...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Macrophage Migration Inhibitory Factor
• Share to Rheumatoid Arthritis Research and Therapies
• Share to Spondyloarthritis Studies and Treatments